Rita Rubin
Senior Writer, Medical News and Perspectives at JAMA: Journal of the American Medical Association
Lead senior staff writer, Medical News @JAMA_current https://t.co/5Y2pgoYNO1 Mountain Mama, Medill & Hopkins alum. Follow me @ritarubin.bsky.social
Articles
-
1 week ago |
jamanetwork.com | Rita Rubin
Their ages and attitudes vary, but most patients who seek care at MD Anderson’s Young-Onset Colorectal Cancer Program have the same top-of-mind question: Program director Y. Nancy You, MD, a colorectal cancer surgeon, can’t provide a solid answer. Really, no one can explain with certainty why colorectal cancer incidence rates have been rising in adults younger than 50 years—sometimes much younger—although environmental exposures and lifestyle factors seem to be leading contenders.
-
3 weeks ago |
jamanetwork.com | Rita Rubin
Alan Morgan, chief executive officer of the National Rural Health Association, was shocked when he read the discretionary 2026 budget passback for the US Department of Health and Human Services (HHS).
-
1 month ago |
jamanetwork.com | Rita Rubin
Pediatrician Mark Miller, MD, MPH, first noticed the red flags when he was in medical school a half-century ago: studies consistently showed that consuming foods colored with synthetic dyes could affect some children’s behavior.
-
1 month ago |
jamanetwork.com | Rita Rubin
The long-time Centers for Disease Control and Prevention (CDC) scientist was getting ready to go for a run before work on April 1 at around 5 am when the email message arrived. It said the staffer had been affected by the agency’s reduction in force (RIF) and would lose access to the CDC’s computer system. No one on their team—consisting of 28 full-time employees and 10 fellows—saw it coming.
-
1 month ago |
jamanetwork.com | Rita Rubin |Lead Senior
It’s been nearly 30 years since Congress, in the Food and Drug Administration (FDA) Modernization Act of 1997, instructed the US Health and Human Services (HHS) secretary to consult with the National Institutes of Health (NIH) director and the pharmaceutical industry to “review and develop guidance, as appropriate, on the inclusion of women and minorities in clinical trials…” In recent weeks, though, such guidance documents and other information about enrolling patients long underrepresented...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 14K
- Tweets
- 17K
- DMs Open
- Yes
Is a handshake enough to seal the deal? And just how much do artificial food dyes actually affect how kids act? My latest for @JAMA_current:
The @FDA is aiming to eliminate synthetic food dyes from foods sold in the US by 2026 due to concerns about their impact on children's behavior, seeking voluntary cooperation from the industry instead of legislation. https://t.co/2456uiAmMA
My latest for @JAMA_current
Experts inside and outside the CDC have been left stunned and puzzled by the decimation of a nearly 80-year-old agency that has been a global leader in public health. Learn how decimating the CDC will cost many lives in the US and abroad. https://t.co/bJnWtNCAdJ
My latest for @JAMA_current
"Diversity is not just about race and ethnicity. Diversity is about the diversity of the human condition." This Medical News article discusses how the dismantling of DEI efforts could lead to less representative clinical trials. https://t.co/RW6KpBfpRX